Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Guillaume Picard"'
Autor:
Omid Aghajanzadeh, Guillaume Picard, Juan Antonio Corrales Ramon, Christophe Cariou, Roland Lenain, Youcef Mezouar
Publikováno v:
2022 IEEE 18th International Conference on Automation Science and Engineering (CASE).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bcf671a852d7ac360ff766dd1966d74
https://doi.org/10.1109/case49997.2022.9926528
https://doi.org/10.1109/case49997.2022.9926528
Publikováno v:
IEEE Robotics and Automation Letters
IEEE Robotics and Automation Letters, 2022, 7 (2), pp.2329-2336. ⟨10.1109/LRA.2022.3143894⟩
IEEE Robotics and Automation Letters, 2022, 7 (2), pp.2329-2336. ⟨10.1109/LRA.2022.3143894⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::701d6b910db7e89ca04399532be513aa
https://hal.inrae.fr/hal-03856781
https://hal.inrae.fr/hal-03856781
Autor:
François Goldwasser, Dorothée Lebert, Nihel Khoudour, Aurélien Millet, Benoit Blanchet, Pauline Bros, Guillaume Picard, Christelle Machon, Jérôme Guitton
Publikováno v:
Talanta
Talanta, Elsevier, 2021, 224, pp.121889-. ⟨10.1016/j.talanta.2020.121889⟩
Talanta, Elsevier, 2021, 224, pp.121889-. ⟨10.1016/j.talanta.2020.121889⟩
Nivolumab is a fully human immunoglobulin G4 used for the treatment of several advanced solid cancers as immune checkpoint inhibitors. There are some challenges for the quantification of mAb in plasma because IgG are present intrinsically in complex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f5cf4808dde657c07ed613c58434a57
https://hal.archives-ouvertes.fr/hal-03492979
https://hal.archives-ouvertes.fr/hal-03492979
Publikováno v:
2020 IEEE Conference on Control Technology and Applications (CCTA)
2020 IEEE Conference on Control Technology and Applications (CCTA), Aug 2020, Montreal, Canada. pp.254-260, ⟨10.1109/CCTA41146.2020.9206371⟩
CCTA
2020 IEEE Conference on Control Technology and Applications (CCTA), Aug 2020, Montreal, Canada. pp.254-260, ⟨10.1109/CCTA41146.2020.9206371⟩
CCTA
International audience; In this paper, the accurate control of mobile robots is investigated in the framework of generic edge following. It proposes a new predictive control approach, based on the minimization of the lateral error along a distance of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9d19bd66e1a1c709688bc10a7dbdc0
https://hal.uca.fr/hal-03042442/file/CCTA20_final.pdf
https://hal.uca.fr/hal-03042442/file/CCTA20_final.pdf
Autor:
Aurélien Millet, Guillaume Picard, Dorothée Lebert, Philippe Ceruse, Jérôme Guitton, Benoit You
Publikováno v:
Therapeutic drug monitoring. 41(4)
Background Cetuximab (CTX) is a chimeric IgG1 Kappa monoclonal antibody used to treat head and neck cancer and colorectal cancer. Previous clinical studies indicated that the pharmacokinetics of CTX influences patient survival. Thus, individualizing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c958b728dd809c043d3d8116f75503
https://pubmed.ncbi.nlm.nih.gov/31306393
https://pubmed.ncbi.nlm.nih.gov/31306393
Introducing plasma/serum glycodepletion for the targeted proteomics analysis of cytolysis biomarkers
Autor:
Guillaume Picard, Yohann Couté, Pauline Maes, Sandrine Donadio-Andréi, Michel Jaquinod, Claire Lacoste, Philippe Ichai, Virginie Brun, Jamila Faivre, Christophe Bruley, Jérôme Garin, Mathilde Louwagie
Publikováno v:
Talanta
Talanta, Elsevier, 2017, 170, pp.473-480. ⟨10.1016/j.talanta.2017.04.042⟩
Talanta, 2017, 170, pp.473-480. ⟨10.1016/j.talanta.2017.04.042⟩
Talanta, Elsevier, 2017, 170, pp.473-480. ⟨10.1016/j.talanta.2017.04.042⟩
Talanta, 2017, 170, pp.473-480. ⟨10.1016/j.talanta.2017.04.042⟩
A major class of clinical biomarkers is constituted of intracellular proteins which are leaking into the blood following ischemia, exposure to toxic xenobiotics or mechanical aggression. Their ectopic presence in plasma/serum is an indicator of tissu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b4e51d8a7920c69b2b07511ad8f56ac
https://hal.archives-ouvertes.fr/hal-02191318
https://hal.archives-ouvertes.fr/hal-02191318
Autor:
Caroline Barau, Benoit Gilquin, Virginie Brun, Myriam Ferro, Guillaume Picard, Leila El Kholy, Brigitte Surin, Michel Jaquinod, Jérôme Garin, Mathilde Louwagie, Thomas Kofman, Emmanuelle Plaisier, Pierre Ronco, Alexandre Cez
Publikováno v:
Talanta
Talanta, 2017, 164, pp.77-84. ⟨10.1016/j.talanta.2016.11.023⟩
Talanta, Elsevier, 2017, 164, pp.77-84. ⟨10.1016/j.talanta.2016.11.023⟩
Talanta, 2017, 164, pp.77-84. ⟨10.1016/j.talanta.2016.11.023⟩
Talanta, Elsevier, 2017, 164, pp.77-84. ⟨10.1016/j.talanta.2016.11.023⟩
There is a need for multiplex, specific and quantitative methods to speed-up the development of acute kidney injury biomarkers and allow a more specific diagnosis. Targeted proteomic analysis combined with stable isotope dilution has recently emerged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c29193f4f0cf9ff5c7849fcc608f7e2e
https://pubmed.ncbi.nlm.nih.gov/28107998
https://pubmed.ncbi.nlm.nih.gov/28107998
Autor:
Elodie Gautier-Veyret, Dorothée Lebert, Jean-François Jourdil, Guillaume Picard, Julia Tonini, Florian Lemaitre, Françoise Stanke-Labesque, Bruno Bonaz
Publikováno v:
Analytical and Bioanalytical Chemistry
Analytical and Bioanalytical Chemistry, 2017, 409 (5), pp.1195-1205. ⟨10.1007/s00216-016-0045-4⟩
Analytical and Bioanalytical Chemistry, Springer Verlag, 2017, 409 (5), pp.1195-1205. ⟨10.1007/s00216-016-0045-4⟩
Analytical and Bioanalytical Chemistry, 2017, 409 (5), pp.1195-1205. ⟨10.1007/s00216-016-0045-4⟩
Analytical and Bioanalytical Chemistry, Springer Verlag, 2017, 409 (5), pp.1195-1205. ⟨10.1007/s00216-016-0045-4⟩
International audience; Infliximab (IFX) is a chimeric monoclonal antibody targeting tumor necrosis factor-alpha. It is currently approved for the treatment of certain rheumatic diseases or inflammatory bowel diseases. Clinical studies have suggested
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3865ba9242cde23e2f3e008435ab805c
https://pubmed.ncbi.nlm.nih.gov/27826630
https://pubmed.ncbi.nlm.nih.gov/27826630
Autor:
Céline Huillet, Mathilde Louwagie, Jérôme Garin, Annie Adrait, Alain Dupuis, Dorothée Lebert, Mathieu Trauchessec, Michel Jaquinod, Virginie Brun, Christophe Bruley, Guillaume Picard
Publikováno v:
PROTEOMICS
Absolute quantification of proteins using isotope dilution mass spectrometry requires the selection of proteotypic peptides. When choosing these peptides, a certain number of rules must be respected. Several of these were established to safeguard aga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7b30dd1ef09a96ff3c75f8c3082e5e2
Autor:
Lysiane Troncy, Bernadette Maynadier, Guillaume Picard, Christine Lacheny, Alain Beck, Michel Jaquinod, Dorothée Lebert, Virginie Brun, Christine Klinguer-Hamour, Walter Low, Nicolas Mouz, Charlotte Beau-Larvor
Publikováno v:
Bioanalysis
Bioanalysis, Future Science, 2015, 7 (10), pp.1237-1251. ⟨10.4155/bio.15.56⟩
Bioanalysis, 2015, 7 (10), pp.1237-1251. ⟨10.4155/bio.15.56⟩
Bioanalysis, Future Science, 2015, 7 (10), pp.1237-1251. ⟨10.4155/bio.15.56⟩
Bioanalysis, 2015, 7 (10), pp.1237-1251. ⟨10.4155/bio.15.56⟩
Background: In preclinical studies, monoclonal antibodies (mAbs) are traditionally assayed by ligand-binding-assays. Recently, quantitative liquid chromatography mass spectrometry (MS)-based assays have emerged which circumvent a number of challenges
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5531ecf6388f66098f9079cb40d7a990
https://hal.archives-ouvertes.fr/hal-02086282
https://hal.archives-ouvertes.fr/hal-02086282